Urinary peptide panel for prognostic assessment of bladder cancer relapse

Non-invasive tools stratifying bladder cancer (BC) patients according to the risk of relapse are urgently needed to guide clinical intervention. As a follow-up to the previously published study on CE-MS-based urinary biomarkers for BC detection and recurrence monitoring, we expanded the investigatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Krochmal, Magdalena, van Kessel, Kim E. M., Zwarthoff, Ellen C., Belczacka, Iwona, Pejchinovski, Martin, Vlahou, Antonia, Mischak, Harald, Frantzi, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529475/
https://www.ncbi.nlm.nih.gov/pubmed/31114012
http://dx.doi.org/10.1038/s41598-019-44129-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529475/
https://www.ncbi.nlm.nih.gov/pubmed/31114012
http://dx.doi.org/10.1038/s41598-019-44129-y

Ejemplares similares